1.34 pm | 20 May 2013 |  Source: CNBC-TV18

The new drug policy is unfavourable to big players feels Kiran Mazumdar Shaw, but adds that Biocon will not be impacted significantly by it....

12.39 pm | 29 Apr 2013 |  Source: CNBC-TV18

In CNBC-TV18's popular show Bull's Eye, Nooresh Merani, AMSEC Research shares his trading strategies for the day....

9.02 am | 29 Apr 2013 |  Source: CNBC-TV18

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting a...

11.50 am | 26 Apr 2013 |  Source: Moneycontrol.com

Biocon at its meeting held on April 25, 2013 has appointed Mr Daniel M Bradbury as an additional director of the company. He will hold office up to th...

11.50 am | 26 Apr 2013 |  Source: Moneycontrol.com

Biocon at its meeting held on April 25, 2013 has recommended a final dividend of Rs 5 per share (i.e. 100%) and a special dividend of Rs 2.50 per shar...

10.00 am | 26 Apr 2013 |  Source: Moneycontrol.com

Biocon's fourth quarter consolidated net profit grew 2.5 times year-on-year to Rs 249 crore, boosted by one time exceptional income of Rs 202 crore. ...

9.32 am | 26 Apr 2013 |  Source: Moneycontrol.com

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting a...

8.51 am | 26 Apr 2013 |  Source: CNBC-TV18

On CNBC-TV18's show Super Six, market gurus Rajesh Jain, Religare Securities, Vikrant Jadeja, vibranttrades.com and Vishal Malkan, malkansview.com, pl...

8.51 am | 26 Apr 2013 |  Source: CNBC-TV18

Hikal | Castrol India | NIIT Tech | JSW Steel | Alok Industries | Biocon | United Spirits | Asian Paints | IDBI Bank | Idea Cellular | JSPL and Maruti...

7.00 pm | 23 Apr 2013 |  Source: CNBC-TV18

Pharmaceutical firm Biocon is set to declare its fourth quarter FY13 numbers on Thursday. Analysts on an average expect the company's profit after tax...

1.30 pm | 16 Apr 2013 |  Source: Moneycontrol.com

Motilal Oswal has come with its March`13 quarterly earning estimates for healthcare sector. The research firm expects a top line growth of 17.4% YoY a...

1.27 pm | 06 Mar 2013 |  Source: Moneycontrol.com

IIFL is bullish on Biocon and has recommended to buy the stock above Rs 272 with a stop loss of Rs 264 for the target price of Rs 288, in its March 06...

12.31 pm | 30 Jan 2013 |  Source: Moneycontrol.com

Sushil Finance has recommended hold rating on Biocon with a target of Rs 312, in its January 29, 2013 research report....

12.29 pm | 30 Jan 2013 |  Source: Moneycontrol.com

Motilal Oswal has maintained neutral rating on Biocon with a target of Rs 315 in its January 28, 2013 research report....

1.27 pm | 29 Jan 2013 |  Source: Moneycontrol.com

Dolat Capital is bullish on Biocon and has recommended accumulate rating on the stock with a target of Rs 312 in its January 28, 2013 research report....

1.09 pm | 25 Jan 2013 |  Source: Moneycontrol.com

Biocon's third quarter (October-December) quarter grew 9 percent year-on-year to Rs 93 crore, as higher expenses compressed margins and offset a good ...

9.12 am | 25 Jan 2013 |  Source: Moneycontrol.com

Biocon group has posted a consolidated net profit after tax and minority interest of Rs 91.76 crore, up 8.14% for the quarter ended December 31, 2012 ...

10.13 am | 24 Jan 2013 |  Source: CNBC-TV18

Healthcare firm Biocon is set to declare its third quarter results on Thursday. Analysts on an average expect profit after tax of the company to grow ...

11.54 am | 12 Jan 2013 |  Source: Moneycontrol.com

Motilal Oswal has come out with its earnings estimates for pharmaceuticals sector for the quarter ended December 2012. The research firm expects the t...